APA (7th ed.) Citation

Bieck, P. R., Leibowitz, M., Lachno, D. R., Ledent, E., Padich, R., & Jhee, S. (2016). Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing. Journal of clinical psychopharmacology, 36(6), 675. https://doi.org/10.1097/JCP.0000000000000611

Chicago Style (17th ed.) Citation

Bieck, Peter R., Mark Leibowitz, D Richard Lachno, Edouard Ledent, Robert Padich, and Stan Jhee. "Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing." Journal of Clinical Psychopharmacology 36, no. 6 (2016): 675. https://doi.org/10.1097/JCP.0000000000000611.

MLA (9th ed.) Citation

Bieck, Peter R., et al. "Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing." Journal of Clinical Psychopharmacology, vol. 36, no. 6, 2016, p. 675, https://doi.org/10.1097/JCP.0000000000000611.